Antagonists of the adenosine A 2A receptor based on a 2-arylbenzoxazole scaffold: Investigation of the C5- and C7-positions to enhance affinity

Archive ouverte

Duroux, Romain | Agouridas, Laurence | Renault, Nicolas | El Bakali, Jamal | Furman, Christophe | Melnyk, Patricia | Yous, Saïd

Edité par CCSD ; Elsevier -

International audience. We have recently reported a series of 2-furoyl-benzoxazoles as potential A2A adenosine receptor (A2AR) antagonists. Two hits were identified with interesting pharmacokinetic properties but were find to bind the hA2AR receptor in the micromolar-range. Herein, in order to enhance affinity toward the hA2AR, we explored the C5- and C7-position of hits 1 and 2 based on docking studies. These modifications led to compounds with nanomolar-range affinity (e.g. 6a, Ki = 40 nM) and high antagonist activity (e.g. 6a, IC50 = 70.6 nM). Selected compounds also exhibited interesting in vitro DMPK (Drug Metabolism and Pharmacokinetics) properties including high solubility and low cytotoxicity. Therefore, the benzoxazole ring appears as a highly effective scaffold for the design of new A2A antagonists.

Suggestions

Du même auteur

Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor

Archive ouverte | Duroux, Romain | CCSD

International audience. The development of adenosine A2A receptor antagonists has received much interest in recent years for the treatment of neurodegenerative diseases. Based on docking studies, a new series of 2-a...

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives

Archive ouverte | Landagaray, Elodie | CCSD

International audience. Following our research for new melatonergic ligands, herein we report the design, synthesis and biological evaluation of new series of naphthofuranic derivatives as MT1 and MT2 ligands. Bindi...

High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists

Archive ouverte | Bolteau, Raphaël | CCSD

International audience. The past fifty years have been marked by the surge of neurodegenerative diseases. Unfortunately, current treatments are only symptomatic. Hence, the search for new and innovative therapeutic ...

Chargement des enrichissements...